SUPPORT THINKCIVICS — Donate HERE
OR Subscribe for free to the ThinkCivics+ newsletter.
NEWS FEED — GAB — FACEBOOK — TWITTER — RUMBLE
Join ThinkCivics+ premium Substack subscription to support independent news. Purchase today to get 25% off your membership! Our independence and ability to speak truth to power depend on all the resources we can get. Help us and become part of the fight!
Artificial intelligence has developed a treatment for cancer in just 30 days and can predict a patient’s survival rate.
In a new study published in the journal Chemical Science, researchers at the University of Toronto along with Insilico Medicine developed a potential treatment for hepatocellular carcinoma (HCC) with an AI drug discovery platform called Pharma.AI.
HCC is the most common type of liver cancer and occurs when a tumor grows on the liver, according to Cleveland Clinic.
Researchers applied AlphaFold, an AI-powered protein structure database, to Pharma.AI to uncover a novel target — a previously unknown treatment pathway — for cancer and developed a “novel hit molecule” that could bind to that target without aid.
The leading source for breaking news, videos, politics, entertainment, opinion, culture, tech, and more.